UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $555,000 Holdings in SunOpta Inc. (NASDAQ:STKL)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC cut its position in SunOpta Inc. (NASDAQ:STKL) (TSE:SOY) by 72.8% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 87,002 shares of the company’s stock after selling 232,339 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in SunOpta were worth $555,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in STKL. Hantz Financial Services Inc. acquired a new stake in SunOpta in the second quarter valued at $42,000. US Bancorp DE raised its holdings in shares of SunOpta by 139.3% in the 3rd quarter. US Bancorp DE now owns 8,197 shares of the company’s stock valued at $52,000 after purchasing an additional 4,772 shares during the period. Ballentine Partners LLC acquired a new stake in SunOpta in the 2nd quarter valued at about $60,000. MQS Management LLC bought a new position in SunOpta during the second quarter worth about $63,000. Finally, Tealwood Asset Management Inc. acquired a new position in SunOpta during the third quarter worth approximately $80,000. 85.39% of the stock is currently owned by institutional investors and hedge funds.

SunOpta Price Performance

Shares of NASDAQ STKL opened at $7.73 on Friday. The firm has a market cap of $923.51 million, a P/E ratio of -42.94 and a beta of 1.78. The business’s 50 day moving average is $7.15 and its 200-day moving average is $6.29. The company has a current ratio of 1.20, a quick ratio of 0.53 and a debt-to-equity ratio of 1.61. SunOpta Inc. has a 1-year low of $4.88 and a 1-year high of $8.11.

SunOpta (NASDAQ:STKL) (TSE:SOY) last issued its quarterly earnings data on Tuesday, November 5th. The company reported $0.02 EPS for the quarter, meeting analysts’ consensus estimates of $0.02. SunOpta had a positive return on equity of 7.92% and a negative net margin of 2.74%. The firm had revenue of $176.22 million for the quarter, compared to analyst estimates of $172.30 million. Equities research analysts predict that SunOpta Inc. will post 0.13 earnings per share for the current year.

Insider Buying and Selling

In other news, Director Rebecca Fisher sold 13,142 shares of SunOpta stock in a transaction that occurred on Tuesday, November 19th. The shares were sold at an average price of $7.58, for a total value of $99,616.36. Following the completion of the sale, the director now directly owns 108,500 shares in the company, valued at approximately $822,430. The trade was a 10.80 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Robert Duchscher sold 50,000 shares of the business’s stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $7.33, for a total value of $366,500.00. Following the completion of the sale, the insider now owns 42,971 shares of the company’s stock, valued at approximately $314,977.43. This trade represents a 53.78 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 6.48% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the company. Stephens raised their price objective on SunOpta from $9.00 to $10.00 and gave the company an “overweight” rating in a research report on Wednesday, November 6th. StockNews.com raised SunOpta from a “sell” rating to a “hold” rating in a report on Saturday, November 9th. Finally, DA Davidson reiterated a “buy” rating and issued a $9.00 price objective on shares of SunOpta in a report on Thursday, October 10th. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $9.50.

SunOpta Profile

SunOpta Inc engages in manufacture and sale of plant-based and fruit-based food and beverage products in the United States, Canada, and internationally. The company provides plant-based beverages utilizing oat, almond, soy, coconut, rice, hemp, and other bases under the Dream and West Life brands; oat-based creamers under the SOWN brand; ready-to-drink protein shakes; and nut, grain, seed, and legume based beverages; packaged teas and concentrates; and meat and vegetable broths and stocks.